Joint Control of Inflammation, Cholesterol, and Lipoprotein(a) With Incident Cardiovascular Events in People With Type 2 Diabetes
Diabetes Obesity and Cardiometabolic CARE · 01.07.2026 · 1 (4) · 671-681
DOI: 10.2337/doc26-0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Obesity and Cardiometabolic CARE, online erschienen am 17.07.2026. Verfasst von Yi-Hsuan Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, FIC NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE We aimed to investigate the joint associations of high-sensitivity C-reactive protein (hsCRP), LDL cholesterol (LDL-C), and lipoprotein(a) [Lp(a)] with cardiovascular disease (CVD) among patients with type 2 diabetes. RESEARCH DESIGN AND METHODS This prospective cohort study identified patients with type 2 diabetes from the UK Biobank. Baseline hsCRP, LDL-C, and Lp(a) were dichotomized according to guideline-recommended target levels. Patients were followed for incident atherosclerotic cardiovascular disease (ASCVD), total CVD (ASCVD plus heart failure), death, or study end. Competing risk models adjusted for important covariates were used. RESULTS There were 29,658 patients with type 2 diabetes who were followed for a median of 15 years. Those with all three biomarkers above target had significantly increased risks compared with those with all at target: fatal and nonfatal ASCVD (adjusted hazard ratio 1.59; 95% CI 1.24, 2.03) and total CVD (adjusted hazard ratio 1.44; 95% CI 1.13, 1.83). Cardiovascular risk increased progressively as fewer biomarkers achieved target levels (all Ptrend < 0.001), with stronger associations in patients with shorter diabetes duration (<2 years vs. ≥2 years). CONCLUSIONS Elevated hsCRP, LDL-C, and Lp(a) showed dose-dependent associations with cardiovascular risk in patients with type 2 diabetes, supporting their control in cardiovascular risk prevention.
Autor:innen und Institutionen
- Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA.
- Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
- Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
ORCID-Profile: Yoriko Heianza, Kuo-Liong Chien, Lu Qi
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- FIC NIH HHS
- NIGMS NIH HHS
- Fogarty International Center
- National Institute of Diabetes and Digestive and Kidney Diseases
- Tulane Research Centers of Excellence Awards
- National Heart, Lung, and Blood Institute
Zitieren
APA
Lin, Y. H., Dai, J., Heianza, Y., Chien, K. L., & Qi, L. (2026). Joint Control of Inflammation, Cholesterol, and Lipoprotein(a) With Incident Cardiovascular Events in People With Type 2 Diabetes. Diabetes Obesity and Cardiometabolic CARE, 1(4), 671-681. https://doi.org/10.2337/doc26-0039
Vancouver
Lin YH, Dai J, Heianza Y, Chien KL, Qi L. Joint Control of Inflammation, Cholesterol, and Lipoprotein(a) With Incident Cardiovascular Events in People With Type 2 Diabetes. Diabetes Obesity and Cardiometabolic CARE. 2026;1(4):671-681. doi:10.2337/doc26-0039
BibTeX
@article{Lin2026,
author = {Lin, Yi-Hsuan and Dai, Jin and Heianza, Yoriko and Chien, Kuo-Liong and Qi, Lu},
title = {Joint Control of Inflammation, Cholesterol, and Lipoprotein(a) With Incident Cardiovascular Events in People With Type 2 Diabetes},
journal = {Diabetes Obesity and Cardiometabolic CARE},
year = {2026},
volume = {1},
number = {4},
pages = {671--681},
doi = {10.2337/doc26-0039}
}
EUVIMED